Recruiting Safety and Efficacy of Pucotenlimab in pLECC NCT06969534 Conditions Carcinoma, Lymphoepithelioma, Lymphoepithelioma-like Carcinoma, +3 more Locations Yizhuo Zhang — Guangzhou, Guangdong, China View Trial Details
Completed Cytotoxic T Cells to Treat Relapsed EBV-positive Lymphoma NCT01956084 Conditions Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +14 more Locations Childrens National Medical Center — Washington D.C., District of Columbia, United States View Trial Details
Completed LMP-specific T-cells for Patients With Relapsed EBV-positive Lymphoma NCT00062868 Conditions Disease Attributes, Hemic and Lymphatic Diseases, Hodgkin Disease, +17 more Locations Texas Children's Hospital — Houston, Texas, United States The Methodist Hospital — Houston, Texas, United States View Trial Details
